Nursing care
Antiarrhythmics: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Antiarrhythmics restore or maintain a normal heart rhythm by altering the electrical conduction of cardiac cells. The nursing priority is monitoring: a baseline ECG and vital signs before the first dose, then ongoing checks of rhythm, rate, and organ function, since several agents in this class are as toxic as they are effective.
What it does and why it is prescribed
Antiarrhythmics are prescribed to convert an abnormal rhythm back to sinus, control ventricular or atrial rate, or prevent a life-threatening rhythm from recurring. They work by blocking sodium, potassium, or calcium channels, or by blocking beta receptors, which slows conduction or prolongs the refractory period of cardiac tissue. The class spans agents used for atrial fibrillation, such as amiodarone and diltiazem, and agents reserved for ventricular arrhythmias, such as lidocaine.
Amiodarone is the one you will see most often on a cardiac or telemetry unit, prescribed for both atrial and ventricular arrhythmias when other agents have failed or are contraindicated. It is effective across a wide range of rhythm disturbances, which is exactly why it is used so widely, and exactly why its toxicity profile matters so much to the nurse giving it.
Nursing considerations before giving it
Obtain a baseline 12-lead ECG and note the QT interval before the first dose of any antiarrhythmic, since most agents in this class prolong QT and can precipitate torsades de pointes. Check baseline potassium and magnesium, because hypokalemia and hypomagnesemia increase the risk of drug-induced arrhythmia and blunt the drug's own effectiveness.
Before giving amiodarone specifically, review baseline thyroid function, liver enzymes, a chest X-ray, and a pulmonary function assessment if one is on the chart. These are not routine admission tests done out of habit — amiodarone accumulates in the thyroid, liver, eyes, and lungs, and the baseline is what later monitoring gets compared against. Confirm IV amiodarone is given through a central line when possible, since peripheral infusion carries a real risk of phlebitis.
What to monitor
Continuous cardiac monitoring during IV administration and initiation of oral therapy, watching rate, rhythm, and QT interval on every strip. Check blood pressure with each dose change, since several antiarrhythmics, amiodarone included, cause hypotension and bradycardia.
For amiodarone, monitoring is the whole nursing job because the drug is toxic to the thyroid, liver, eyes, and lungs even at therapeutic levels. Thyroid function tests every six months, liver enzymes periodically, an annual ophthalmic exam for corneal microdeposits, and a chest X-ray or pulmonary function test if the patient develops a new cough or dyspnea, which can signal amiodarone pulmonary toxicity. Report a resting heart rate below 60, a QTc over 500 milliseconds, new visual halos, unexplained weight change, or a persistent dry cough.
Side effects versus adverse effects
Expected side effects across the class include mild bradycardia, transient hypotension, and gastrointestinal upset, all of which are usually tolerable and do not require stopping the drug. With amiodarone, expect a bluish-grey skin discoloration with long-term use and photosensitivity, which is cosmetic and reversible but worth teaching the patient about in advance.
Adverse effects are the ones that demand the drug be held and the prescriber notified: pulmonary fibrosis, hepatotoxicity with rising liver enzymes, hyperthyroidism or hypothyroidism from amiodarone's iodine content, corneal deposits affecting vision, and any new ventricular arrhythmia, which is proarrhythmia rather than treatment failure. The distinction is severity and reversibility — a side effect the patient lives with, an adverse effect that changes the plan of care.
What to hold for and when to call
Hold the dose and notify the provider for a heart rate below 60 beats per minute unless a faster rate range has been ordered, a systolic blood pressure below 90 mmHg, a QTc prolonged beyond the facility's threshold, or any new heart block on the monitor.
Call promptly for signs of amiodarone toxicity: new or worsening shortness of breath and cough suggesting pulmonary involvement, jaundice or right upper quadrant pain suggesting liver injury, unexplained tremor or weight loss suggesting thyroid dysfunction, or visual changes. None of these are reasons to panic, but all of them are reasons the next dose should not go in until the provider has weighed in.
Patient teaching
Teach the patient to check their own pulse before each dose and to hold the medication and call the clinic if it falls below the parameter they have been given, usually 60. Explain that missing doses or stopping abruptly can allow the arrhythmia to return, so the drug is not one to self-adjust.
For amiodarone, teach sun protection, since photosensitivity can cause a severe burn even through light cloud cover, and warn about the possibility of a grey-blue skin tint with months of use. Stress the importance of keeping every scheduled thyroid test, liver panel, and eye exam, because amiodarone toxicity develops slowly and is caught early only through that surveillance, not through symptoms the patient would notice on their own.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our cardiovascular practice questions are the closest set to what this page covers.
Common questions
Why does amiodarone need thyroid testing when it's a heart drug?
Amiodarone is roughly 37% iodine by weight, and that iodine load can push the thyroid toward either hyperthyroidism or hypothyroidism. Thyroid function tests are checked before starting the drug and then every six months for the duration of therapy, because the change can be subtle and slow.
What heart rate should stop a dose of an antiarrhythmic?
A resting heart rate below 60 beats per minute is the general threshold to hold and notify the provider, unless a different parameter is specifically ordered. Bradycardia is an expected class effect, but a rate below that cutoff needs a decision from the prescriber before the next dose.
Is skin discoloration from amiodarone dangerous?
The bluish-grey skin tint that develops with long-term amiodarone use is a cosmetic side effect, not a sign of organ toxicity. It is slowly reversible after the drug is stopped, but patients should still be told about it before it appears so it is not mistaken for something more serious.
What ECG change should a nurse never ignore with antiarrhythmics?
QT interval prolongation is the change to watch most closely, since a QTc that climbs too far raises the risk of torsades de pointes, a life-threatening ventricular arrhythmia. Any significant QTc increase from baseline should be reported before the next dose is given.
More on cardiovascular
Guides on this